Certara said this week that it has signed a partnership with ChemAxon that will allow it to provide its customers with access to ChemAxon’s MarvinSketch and JChem Cartridge for Oracle through its D360 solution.

Certara’s D360 is an integrated solution for querying, analyzing, and visualization scientific data used by pharmaceutical and biotech companies to access data sources for drug discovery and development. This agreement will provide D360 customers with MarvinSketch, which is a chemical structure sketching tool, and the JChem Chemistry data cartridge.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."